131 related articles for article (PubMed ID: 16822576)
21. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
22. [Rationale of antiangiogenic therapy].
Tímár J; Paku S; Tóvári J; Döme B
Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
[TBL] [Abstract][Full Text] [Related]
23. Recombinant antibodies for the selective targeting of tumor neovasculature.
Viti F; Giovannoni L; Neri D
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):204-13. PubMed ID: 11926127
[TBL] [Abstract][Full Text] [Related]
24. History of research on angiogenesis.
Ribatti D
Chem Immunol Allergy; 2014; 99():1-14. PubMed ID: 24217600
[TBL] [Abstract][Full Text] [Related]
25. Feedback mechanism between blood vessels and astrocytes in retinal vascular development.
Kubota Y; Suda T
Trends Cardiovasc Med; 2009 Feb; 19(2):38-43. PubMed ID: 19577710
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.
Van Langendonckt A; Donnez J; Defrère S; Dunselman GA; Groothuis PG
Mol Hum Reprod; 2008 May; 14(5):259-68. PubMed ID: 18430758
[TBL] [Abstract][Full Text] [Related]
27. Current insights on the biology and clinical aspects of VEGF regulation.
Birk DM; Barbato J; Mureebe L; Chaer RA
Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
30. Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis.
Scott AN; Hetheridge C; Reynolds AR; Nayak V; Hodivala-Dilke K; Mellor H
Angiogenesis; 2008; 11(4):337-46. PubMed ID: 18758974
[TBL] [Abstract][Full Text] [Related]
31. Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery.
Cooney MM; van Heeckeren W; Bhakta S; Ortiz J; Remick SC
Nat Clin Pract Oncol; 2006 Dec; 3(12):682-92. PubMed ID: 17139319
[TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenic effects of the fruit of Alpinia oxyphylla.
He ZH; Ge W; Yue GG; Lau CB; He MF; But PP
J Ethnopharmacol; 2010 Nov; 132(2):443-9. PubMed ID: 20723592
[TBL] [Abstract][Full Text] [Related]
33. Cellular abnormalities of blood vessels as targets in cancer.
Baluk P; Hashizume H; McDonald DM
Curr Opin Genet Dev; 2005 Feb; 15(1):102-11. PubMed ID: 15661540
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis in life, disease and medicine.
Carmeliet P
Nature; 2005 Dec; 438(7070):932-6. PubMed ID: 16355210
[TBL] [Abstract][Full Text] [Related]
35. Biomedical aspects of targeted delivery of drugs to pulmonary endothelium.
Muzykantov VR
Expert Opin Drug Deliv; 2005 Sep; 2(5):909-26. PubMed ID: 16296786
[TBL] [Abstract][Full Text] [Related]
36. Targeting coagulation to the tumor microvasculature: perspectives and therapeutic implications from preclinical studies.
Narazaki M; Tosato G
J Natl Cancer Inst; 2005 May; 97(10):705-7. PubMed ID: 15900035
[No Abstract] [Full Text] [Related]
37. Manipulating angiogenesis in medicine.
Carmeliet P
J Intern Med; 2004 May; 255(5):538-61. PubMed ID: 15078497
[TBL] [Abstract][Full Text] [Related]
38. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.
Goodwin AM
Microvasc Res; 2007; 74(2-3):172-83. PubMed ID: 17631914
[TBL] [Abstract][Full Text] [Related]
39. Design of vascular endothelium-specific drug-targeting strategies for the treatment of cancer.
Molema G
Acta Biochim Pol; 2005; 52(2):301-10. PubMed ID: 15990916
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of radiation therapy by vascular targeting agents.
Siemann DW; Horsman MR
Curr Opin Investig Drugs; 2002 Nov; 3(11):1660-5. PubMed ID: 12476970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
